Regenerative therapy and cancer: In vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates

Tissue Engineering - Part A

Volumn 17, Issue 1-2, 2011, Pages 93-106

  Zimmerlin, Ludovic ^a,b   Donnenberg, Albert D ^a,b,c   Rubin, J Peter ^b,c   Basse, Per ^a   Landreneau, Rodney J ^b,d   Donnenberg, Vera S ^a,b,c,d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^d Heart Lung and Esophageal Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; FLOW CYTOMETRY; GRAFTS; STEM CELLS;

ADIPOSE DERIVED STEM CELLS; BONE MARROW MESENCHYMAL STEM CELLS; BREAST CANCER; BREAST CANCER CELLS; CLINICAL ISOLATES; COCULTURE; HORMONE LEPTIN; IMMUNOPHENOTYPES; IMMUNOSTAINING; IN-VITRO; IN-VIVO; PLEURAL EFFUSION; RECONSTRUCTIVE SURGERY; SECRETOME; TUMOR CELLS; TUMORIGENESIS;

CELL CULTURE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; ARTICLE; BONE DEVELOPMENT; BREAST TUMOR; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CYTOLOGY; DRUG SCREENING; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MOUSE; PHYSIOLOGY; STEM CELL; STEM CELL TRANSPLANTATION; TUMOR CELL CULTURE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROGENESIS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; OSTEOGENESIS; STEM CELL TRANSPLANTATION; STEM CELLS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78650871554     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0248     Document Type: Article

References (38)

1. Neuber, G.A. Fettransplantation. Chir Kongr Verhandl Deutsche Gesellschaft für Chirurgie 22, 66, 1893.
2. Czerny, V. Plastischer Ersatz der Brustdruse durch ein Li-pom. Chir Kong Verhandl 2, 216, 1895.
3. ASPRS. Report on autologous fat transplantation. ASPRS Ad-Hoc Committee on New Procedures, September 30, 1987. Plast Surg Nurs 7, 140, 1987.
4. Delay, E., Garson, S., Tousson, G., and Sinna R. Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 29, 360, 2009.
5. Peer, L.A. Loss of Weight and Volume in Human Fat Grafts: With Postulation of A "Cell Survival Theory." Plast Reconstr Surg 5, 217, 1950.
6. Calabria, R., and Hills, B. Fat grafting: fact or fiction? Aes-thet Surg J 25, 55, 2005.
7. Billings, E., Jr., and May, J.W., Jr. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 83, 368, 1989.
8. Nguyen, A., Pasyk, K.A., Bouvier, T.N., Hassett, C.A., and Argenta, L.C. Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg 85, 378; discussion 87, 1990.
9. Moseley, T.A., Zhu, M., and Hedrick, M.H. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 118, 121S, 2006.
10. Yoshimura, K., Sato, K., Aoi, N., Kurita, M., Hirohi, T., and Harii, K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg 32, 48; discussion 6, 2008.
11. Zhu, M., Zhou, Z., Chen, Y., Schreiber, R., Ransom, J.T., Fraser, J.K., et al. Supplementation of fat grafts with adipose-derived regenerative cells improves long-term graft retention. Ann Plast Surg 64, 222, 2010.
12. Miranville, A., Heeschen, C., Sengenes, C., Curat, C.A., Busse, R., and Bouloumie, A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110, 349, 2004.
13. Planat-Benard, V., Silvestre, J.S., Cousin, B., Andre, M., Nibbelink, M., Tamarat, R., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656, 2004.
14. Gronthos, S., Franklin, D.M., Leddy, H.A., Robey, P.G., Storms, R.W., and Gimble, J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189, 54, 2001.
15. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
16. Strem, B.M., Hicok, K.C., Zhu, M., Wulur, I., Alfonso, Z., Schreiber, R.E., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54, 132, 2005.
17. Brewster, A.M., Hortobagyi, G.N., Broglio, K.R., Kau, S.W., Santa-Maria, C.A., Arun, B., et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100, 1179, 2008.
18. Donnenberg, V.S., Donnenberg, A.D., Zimmerlin, L., Land-reneau, R.J., Bhargava, R., Wetzel, R.A., et al. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Clin Cytometry 2010 [Epub ahead of print].
19. Donnenberg, V.S., Luketich, J.D., Landreneau, R.J., DeLoia, J.A., Basse, P., and Donnenberg, A.D. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Found Symp Proc 5, 245, 2006.
20. Zimmerlin, L., Donnenberg, V.S., and Donnenberg, A.D. Rare event detection and analysis in flow cytometry: bone marrow mesenchymal stem cells, breast cancer stem/ progenitor cells in malignant effusions, and pericytes in disaggregated adipose tissue. In: Hawley, T.S., and Hawley, R.G., eds. Flow Cytometry Protocols. Third Edition. New York: Humana Press, 2011 (In press).
21. Zimmerlin, L., Donnenberg, V.S., Pfeifer, M.E., Meyer, E.M., Peault, B., Rubin, J.P., et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 77A, 22, 2010.
22. Donnenberg, A.D. Statistics of immunological testing. In: O'Gorman, M.R., and Donnenberg, A.D., eds. Handbook of Human Immunology. Second Edition. Boca Raton: CRC Press Taylor and Francis, 2008. p. 29.
23. Donnenberg, A.D., and Donnenberg, V.S. Rare-event analysis in flow cytometry. Clin Lab Med 27, 627, viii, 2007.
24. Horny, H.P., Menke, D.M., and Kaiserling, E. Neoplastic human tissue mast cells express the adhesion molecule CD44/HCAM. Virchows Arch 429, 91, 1996.
25. Ross, J.A., Ansell, I., Hjelle, J.T., Miller-Hjelle, M.A., and Dobbie, J.W. Phenotypic and functional characterisation of human mesothelial cells. Tissue Antigens 55, 2, 2000.
26. Donnenberg, V.S., Landreneau, R.J., and Donnenberg, A.D. Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. J Control Release 122, 385, 2007.
27. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
28. da Silva Meirelles, L., Fontes, A.M., Covas, D.T., and Caplan, A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20, 419, 2010.
29. Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., et al. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res 69, 836, 2009.
30. Muehlberg, F.L., Song, Y.H., Krohn, A., Pinilla, S.P., Droll, L.H., Leng, X., et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30, 589, 2009.
31. Pinilla, S., Alt, E., Abdul Khalek, F.J., Jotzu, C., Muehlberg, F., Beckmann, C., et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 284, 80, 2009.
32. Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557, 2007.
33. Naumov, G.N., MacDonald, I.C., Chambers, A.F., and Groom, A.C. Solitary cancer cells as a possible source of tumour dormancy? Semin Cancer Biol 11, 271, 2001.
34. Konstantinovsky, S., Smith, Y., Zilber, S., Tuft Stavnes, H., Becker, A.M., Nesland, J.M., et al. Breast carcinoma cells in primary tumors and effusions have different gene array profiles. J Oncol 2010, 969084, 2009.
35. Grogan, W.M., Haar, J.L., Scott, R.B., and Collins, J.M. Applications of light scatter to separation of stem cells. Blood Cells 6, 625, 1980.
36. Vona-Davis, L., and Rose, D.P. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 14, 189, 2007.
37. Goodwin, P.J., Ennis, M., Fantus, I.G., Pritchard, K.I., Tru-deau, M.E., Koo, J., et al. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23, 6037, 2005.
38. Iyengar, P., Combs, T.P., Shah, S.J., Gouon-Evans, V., Pollard, J.W., Albanese, C., et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22, 6408, 2003.